MABPHARM-B: Zhang Yanyun has been appointed as the Chief Independent Non-Executive Director
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, MABPHARM-B announced that starting from October 31, 2025: Executive Director Dr. Qian Weizhu has been appointed as a member of the company's nomination committee; Executive Director Mr. Tao Jing will no longer serve as a member of the nomination committee; and Dr. Zhang Yanyun (the company's independent non-executive director, chairman of the remuneration committee, and member of the nomination committee) has been designated as the Chief Independent Non-Executive Director
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments